Zocor
Company: Merck
Approval Status: Approved November 1997
Treatment for: high triglyceride levels
Areas: Cardiology/Vascular Diseases
General Information
Other Useful Resources
Zocor (simvastatin) has been approved as a treatment for lowering triglyceride levels in addition to its established role of lowering total and LDL (bad) cholesterol in patients with both high cholesterol and high triglycerides. Triglycerides are blood fats that may be elevated in people with high cholesterol and heart disease. In patients with high cholesterol alone or with high cholesterol and triglycerides, Zocor is also indicated as
- An adjunct to diet to reduce triglycerides, as well as total and LDL cholesterol levels
- A drug for reducing the risk of first stroke or transient ischemic attack in people with high cholesterol and coronary artery disease (those who are at the highest risk for cardiovascular events)
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
